Back to Explorer

21CFR207.55

§ 207.55 What additional drug listing information may FDA require?

Regulation Text

For a particular listed drug, upon our request, the registrant must briefly state the basis for its belief that the drug is not subject to section 505 or 512 of the Federal Food, Drug, and Cosmetic Act or section 351 of the Public Health Service Act.

Authority

21 U.S.C. 321,331,351,352,355,360,360b,371,374,381,393;42 U.S.C. 262,264,271.

View in Graph Explorer
21CFR207.55 — § 207.55 What additional drug listing information may FDA require? | CFR Explorer | BioRegHub